The Effect of Fascia Iliaca Compartment Block (FICB) on QoR-15 Score in Partial Hip Arthroplasty Surgery

Sponsor
Basaksehir Cam & Sakura Şehir Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05965544
Collaborator
(none)
60
1
2
3
19.9

Study Details

Study Description

Brief Summary

It reduces pain scores in patients with block and improves the quality of recovery in the postoperative period. In patients who will undergo spinal anesthesia, it will be questioned whether the application of the block before or after surgery makes a difference in the quality of recovery.

Condition or Disease Intervention/Treatment Phase
N/A

Detailed Description

American Society of Anesthesiologists (ASA) physical status I-III patients who are planned for partial hip arthroplasty will be studied in patients over 65 years of age. The patients will be equally randomized into two groups using a computer-generated random number table. In the preoperative period, according to whether FIBP was before or after spinal anesthesia, it will be named as a separate group as Group PreS (Pre-Spinal) and Group PostS (Post-Spinal). The patient will be placed in the lateral decubitus position with the fractured side up. After the spinal anesthesia method was provided with aseptic conditions, 10 mg 0.5% isobaric bupivacaine + 20 mcg Fentanyl injection will be applied using a 26 Gauge pencil point needle through the L3-L4 or L4-L5 intervertebral space. After the patients are in the supine position and aseptic conditions are provided, the fascia on the Iliacus muscle will be determined with the help of an 8-12 MHz linear probe, and the block will be applied with the in-plane technique. During the block, patients will routinely administer 0.2% bupivacaine concentration of 0.5 mL/kg. Demographic data, operation time, perioperative analgesic and sedation need, postoperative pain scores, additional analgesic need, hospitalization and 24th-hour recovery scores will be evaluated.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The patients were equally randomized into two groups using a computer-generated random number table. In the preoperative period, according to whether FIBP was before or after spinal anesthesia, it was named as a separate group as Group PreS (Pre-Spinal) and Group PostS (Post-Spinal).The patients were equally randomized into two groups using a computer-generated random number table. In the preoperative period, according to whether FIBP was before or after spinal anesthesia, it was named as a separate group as Group PreS (Pre-Spinal) and Group PostS (Post-Spinal).
Masking:
Double (Care Provider, Outcomes Assessor)
Masking Description:
After each patient's eligibility has been assessed, numbered and sealed envelopes will be used to conceal assignment status. The same clinician (E.M.) will perform the patient's pre- and post-operative procedures. A researcher who does not know which method was applied to the patient in the perioperative and postoperative follow-ups will be included as double-blind.
Primary Purpose:
Supportive Care
Official Title:
The Effect of Application of Fascia Iliaca Compartment Block (FICB) Before or After Spinal Anesthesia on QoR-15 Score in Partial Hip Arthroplasty Surgery
Anticipated Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Nov 1, 2023
Anticipated Study Completion Date :
Nov 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Group PreS

The block will be applied in the preoperative period

Drug: Bupivacain (preoperative)
After the patients are in the supine position and aseptic conditions are provided in the preoperative period, the fascia on the iliacus muscle will be determined with the help of an 8-12 MHz linear probe and a block will be applied with the in-plane technique. During the block, 0.2% bupivacaine concentration 0.5 mL/kg is routinely used in patients.
Other Names:
  • Preoperative Fascia Iliaca Compartment Block
  • Drug: Bupivacaine-fentanyl
    The patient will be placed in the lateral decubitus position with the fractured side up. After the spinal anesthesia method was provided with aseptic conditions, 10 mg 0.5% bupivacaine + 20 mcg Fentanyl injection will be applied using a 26 Gauge pencil point needle through the L3-L4 or L4-L5 intervertebral space
    Other Names:
  • Spinal Anesthesia
  • Active Comparator: Group PostS

    The block will be applied in the postoperative period

    Drug: Bupivacaine-fentanyl
    The patient will be placed in the lateral decubitus position with the fractured side up. After the spinal anesthesia method was provided with aseptic conditions, 10 mg 0.5% bupivacaine + 20 mcg Fentanyl injection will be applied using a 26 Gauge pencil point needle through the L3-L4 or L4-L5 intervertebral space
    Other Names:
  • Spinal Anesthesia
  • Drug: Bupivacain (Postoperative)
    After the patients are in the supine position and aseptic conditions are provided in the postoperative period, the fascia on the iliacus muscle will be determined with the help of an 8-12 MHz linear probe and a block will be applied with the in-plane technique. During the block, 0.2% bupivacaine concentration 0.5 mL/kg is routinely used in patients.
    Other Names:
  • Postoperative Fascia Iliaca Compartment Block
  • Outcome Measures

    Primary Outcome Measures

    1. Change from baseline QoR-15 at 24 hours postoperatively [Postoperative 24th-hours]

      The patient-reported Turkish QoR-15 score includes 15 questions that evaluate the patient's postoperative recovery. The QoR-15 score is grouped under two groups, A and B. A high QoR-15 score, a score between 0 (poor) and 10 (excellent) for each item, and a total score of 150 indicate better quality of recovery.

    Secondary Outcome Measures

    1. Change from baseline Nursing Delirium Screening Scale (N-DSS) at 24 hours postoperatively [Postoperative 24th-hours]

      Postoperative delirium will be determined with the Nursing Delirium Screening Scale (N-DSS), an easily applicable five-item screening tool that evaluates disorientation, inappropriate behavior, inappropriate communication, hallucination, and psychomotor retardation. Each item scores between 0 and 2 and the total score varies between 0 and 10.

    2. Postoperative nausea and vomiting [Postoperative 24th hour]

      The frequency of nausea and vomiting in the postoperative period was calculated according to the Numeric Rank Score (NRS), which ranged from 0 to 3. Nausea-vomiting status of the patients: 0 points if there is no nausea and vomiting; 1 point if there is nausea, no vomiting; It is scored as 2 points if there is vomiting once and 3 points if there are two or more vomiting attacks.

    3. Analgesic consumption [Postoperative 24th hour]

      The value in mg of the amount of analgesic consumed in the postoperative period

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    65 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Partial Hip Arthroplasty

    • American Society of Anesthesiologists (ASA) physical status I-III,

    • Patients aged ≥ 65 years

    Exclusion criteria:
    • Contraindication for central or peripheral blocks,

    • Cognitive Dysfunction,

    • History of chronic opioid use,

    • Previous hip surgery,

    • Serious organ dysfunction,

    • Allergy to any drug used in the study,

    • Body mass index (BMI) ≥30,

    • Infection in the area to be treated,

    • Refusal to participate in the study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ergun Mendes Küçükçekmece İ̇stanbul Turkey 34000

    Sponsors and Collaborators

    • Basaksehir Cam & Sakura Şehir Hospital

    Investigators

    • Principal Investigator: Ergun Mendes, Basaksehir Cam & Sakura Şehir Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Ergün Mendeş, Principal Investigator, Basaksehir Cam & Sakura Şehir Hospital
    ClinicalTrials.gov Identifier:
    NCT05965544
    Other Study ID Numbers:
    • e.mendes - 2
    • KAEK/2023.06.259
    First Posted:
    Jul 28, 2023
    Last Update Posted:
    Aug 1, 2023
    Last Verified:
    Jul 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Ergün Mendeş, Principal Investigator, Basaksehir Cam & Sakura Şehir Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 1, 2023